AZIZ SHAIBANI to Disease Progression
This is a "connection" page, showing publications AZIZ SHAIBANI has written about Disease Progression.
Connection Strength
0.040
-
Safety and efficacy of arimoclomol for inclusion body myositis: a multicentre, randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2023 10; 22(10):900-911.
Score: 0.025
-
Safety and efficacy of ranirestat in patients with mild-to-moderate diabetic sensorimotor polyneuropathy. J Peripher Nerv Syst. 2015 Dec; 20(4):363-71.
Score: 0.015